Ticker
ABOSCompany Name
ACUMEN PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Core Assets | Goodwill and Intangibles |
---|---|---|---|---|
6/30/2025 | $ 171.9M | $ 37.04M | $ 134.85M | $ 0 |
3/31/2025 | $ 204.48M | $ 30.39M | $ 174.09M | $ 0 |
12/31/2024 | $ 238.99M | $ 35.86M | $ 203.13M | $ 0 |
9/30/2024 | $ 266.98M | $ 33.42M | $ 233.56M | $ 0 |
6/30/2024 | $ 288.91M | $ 68.19M | $ 220.72M | $ 0 |
3/31/2024 | $ 300.97M | $ 47.16M | $ 253.8M | $ 0 |
12/31/2023 | $ 310.13M | $ 67.12M | $ 243.01M | $ 0 |
9/30/2023 | $ 286.37M | $ 95.11M | $ 191.26M | $ 0 |
6/30/2023 | $ 177.41M | $ 77.25M | $ 100.16M | $ 0 |
3/31/2023 | $ 187.86M | $ 78M | $ 109.86M | $ 0 |
Assets - Intangibles - CashnEq
(=) Core Assets
Core Assets for ACUMEN PHARMACEUTICALS INC is calculated as follows: Assets [ $ 42.37M ] - Intangibles [ $ 0 ] - CashnEq [ $ 41.41M ]
(=) Core Assets [ $ 966K ]
Minimum
Mar 31, 2021
Maximum
Mar 31, 2024
Average
Median
filtered constituents | 3.42K |
---|---|
min | $ 0 |
max | $ 4.42B |
average | $ 803.6M |
median | $ 289.12M |
std | $ 1.06B |